Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial progenitor cells for postnatal vasculogenesis.

Takayuki Asahara1, Atsuhiko Kawamoto

  • 1Stem Cell Translational Research, Kobe Institute of Biomedical Research and Innovation/Riken Center for Developmental Biology, 2-2 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. asa777@aol.com

American Journal of Physiology. Cell Physiology
|August 17, 2004
PubMed
Summary

Researchers identified circulating endothelial progenitor cells (EPCs) that home to sites of neovascularization and differentiate into endothelial cells. This discovery supports cell therapy for tissue regeneration and vascular medicine applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial and Functional Immune Profiling Identifies Impaired Vascular Repair in Human Myocardial Infarction.

Biomedicines·2026
Same author

Development of a Novel Risk Assessment Scale to Improve the Consistency and Reliability of Risk-Based Approaches in Clinical Trials.

Therapeutic innovation & regulatory science·2026
Same author

Prevalence and Clinical Characteristics of Patients With Heart Failure With Preserved Ejection Fraction Who Meet the Obesity-Related Eligibility Criteria for Subcutaneous Incretin Receptor Agonists in Japan - Insights From the PARACLETE Study.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Long-term safety and efficacy of filgotinib in patients with idiopathic multicentric Castleman disease: 52-week results from a Phase Ib clinical trial.

Modern rheumatology·2026
Same author

First-in-human study to investigate the safety and efficacy of effective-mononuclear cell therapy for radiogenic xerostomia.

Regenerative therapy·2026
Same author

Prevalence, Characteristics, and Pharmacological Strategies in Patients With Heart Failure With Supranormal Ejection Fraction - Insights From the PARACLETE Study.

Circulation journal : official journal of the Japanese Circulation Society·2025

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Vascular biology

Background:

  • Adult organs contain quiescent stem/progenitor cells alongside differentiated cells.
  • These stem cells activate for tissue regeneration in response to stimuli.
  • Endothelial progenitor cells (EPCs) are a type of circulating progenitor cell.

Purpose of the Study:

  • To review the biological features of EPCs.
  • To explore the potential utility of EPCs in vascular and general medicine.
  • To discuss the role of EPCs in neovascularization and tissue repair.

Main Methods:

  • Isolation of EPCs from peripheral blood using specific cell surface markers (CD34, Flk-1, AC133).
  • Observation of EPC incorporation into neovascularization sites.

Related Experiment Videos

  • Review of existing literature on EPC biology and therapeutic potential.
  • Main Results:

    • Circulating EPCs were identified and isolated.
    • EPCs were shown to home to sites of neovascularization.
    • EPCs differentiate into endothelial cells in situ, supporting vasculogenesis.

    Conclusions:

    • EPCs play a role in postnatal neovascularization, complementing angiogenesis.
    • EPC transplantation shows therapeutic potential in animal models of ischemia.
    • EPCs offer promising applications for cell therapy in vascular and general medicine.